Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Vincent

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Investigation|April 5, 2017
Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host diseaseDanny W Bruce, Heather E Stefanski, Benjamin G Vincent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
Cancer Immunology Research|April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint InhibitorsMaria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
Blood|August 31, 2017
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHDJonathan C Poe, Wei Jia, Hsuan Su, et al.
Blood Advances|December 8, 2022
Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMTKelly S Olsen, Othmane Jadi, Sarah Dexheimer, et al.
Communications Medicine|January 8, 2025
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Blood Cancer Discovery|November 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaJoshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, et al.
Transplantation and Cellular Therapy|April 21, 2021
Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell TransplantationCharlotte McIlwaine Story, Tao Wang, Vijaya Raj Bhatt, et al.
The Lancet. Haematology|March 31, 2024
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30<sup>+</sup> lymphoma: a phase 1 studyNatalie S Grover, George Hucks, Marcie L Riches, et al.
Research Square|January 3, 2024
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|April 5, 2017
Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host diseaseDanny W Bruce, Heather E Stefanski, Benjamin G Vincent, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
Cancer Immunology Research|April 1, 2022
Hallmarks of Resistance to Immune-Checkpoint InhibitorsMaria Karasarides, Alexandria P Cogdill, Paul B Robbins, et al.
Blood|August 31, 2017
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHDJonathan C Poe, Wei Jia, Hsuan Su, et al.
Blood Advances|December 8, 2022
Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMTKelly S Olsen, Othmane Jadi, Sarah Dexheimer, et al.
Communications Medicine|January 8, 2025
Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Blood Cancer Discovery|November 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaJoshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, et al.
Transplantation and Cellular Therapy|April 21, 2021
Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell TransplantationCharlotte McIlwaine Story, Tao Wang, Vijaya Raj Bhatt, et al.
The Lancet. Haematology|March 31, 2024
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30<sup>+</sup> lymphoma: a phase 1 studyNatalie S Grover, George Hucks, Marcie L Riches, et al.
Research Square|January 3, 2024
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Pageof 11